Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study. (ανοίγει νέο παράθυρο)

Abdelrazik N, Fouda M

Πηγή‎: Hematology 2007;12(6):533-41.

Καταχώριση‎: PubMed 17852440

DOI‎: 10.1080/10245330701521572

https://www.ncbi.nlm.nih.gov/pubmed/17852440 (ανοίγει νέο παράθυρο)

Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trial. (ανοίγει νέο παράθυρο)

Cabanillas ME, Kantarjian H, Thomas DA, Mattiuzzi GN, Rytting ME, Bruera E, Xiao L, Bekele BN, Foudray MC, Cortes JE.

Πηγή‎: Cancer 2012;118(3):848-55.

Καταχώριση‎: PubMed 21751205

DOI‎: 10.1002/cncr.26341

https://www.ncbi.nlm.nih.gov/pubmed/21751205 (ανοίγει νέο παράθυρο)

Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment. (ανοίγει νέο παράθυρο)

Corapcioglu F, Aksu G, Basar EZ, Demirel A, Oncel S, Mutlu A

Πηγή‎: Pediatr Hematol Oncol 2008;25(6):509-21.

Καταχώριση‎: PubMed 18728970

DOI‎: 10.1080/08880010802235132

https://www.ncbi.nlm.nih.gov/pubmed/18728970 (ανοίγει νέο παράθυρο)

Recombinant human erythropoietin beta: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients. (ανοίγει νέο παράθυρο)

Durmaz O, Demirkaya M, Sevinir B

Πηγή‎: Pediatr Hematol Oncol 2011;28(6):461-8.

Καταχώριση‎: PubMed 21707225

DOI‎: 10.3109/08880018.2011.570857

https://www.ncbi.nlm.nih.gov/pubmed/21707225 (ανοίγει νέο παράθυρο)

Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. (ανοίγει νέο παράθυρο)

Engert A, Josting A, Haverkamp H, Villalobos M, Lohri A, Sökler M, Zijlstra J, Sturm I, Topp MS, Rank A, Zenz T, Vogelhuber M, Nogova L, Borchmann P, Fuchs M, Flechtner HH, Diehl V.

Πηγή‎: J Clin Oncol 2010;28(13):2239-45.

Καταχώριση‎: PubMed 20368566

DOI‎: 10.1200/JCO.2009.25.1835

https://www.ncbi.nlm.nih.gov/pubmed/20368566 (ανοίγει νέο παράθυρο)

Treatment patterns and outcomes in management of solid cancer patients suffering from anemia in Penang hospital. (ανοίγει νέο παράθυρο)

Hassan BA, Yusoff ZB

Πηγή‎: Asian Pac J Cancer Prev 2011;12(6):1573-6.

Καταχώριση‎: PubMed 22126501

https://www.ncbi.nlm.nih.gov/pubmed/22126501 (ανοίγει νέο παράθυρο)

Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia. (ανοίγει νέο παράθυρο)

Hernandez E, Ganly P, Charu V, Dibenedetto J, Tomita D, Lillie T, Taylor K; ARANESP 20030232 Study Group

Πηγή‎: Curr Med Res Opin 2009;25(9):2109-20.

Καταχώριση‎: PubMed 19601709

DOI‎: 10.1185/03007990903084164

https://www.ncbi.nlm.nih.gov/pubmed/19601709 (ανοίγει νέο παράθυρο)

Hemoglobin response and improvements in quality of life in anemic children with cancer receiving myelosuppressive chemotherapy. (ανοίγει νέο παράθυρο)

Hinds PS, Hockenberry M, Feusner J, Hord JD, Rackoff W, Rozzouk BI

Πηγή‎: J Support Oncol 2005;3(6 Suppl 4):10-1.

Καταχώριση‎: PubMed 16355549

https://www.ncbi.nlm.nih.gov/pubmed/16355549 (ανοίγει νέο παράθυρο)

The efficacy of recombinant human erythropoietin in treatment chemotherapy induced anemia in children diagnosed with a solid cancer. (ανοίγει νέο παράθυρο)

Hiradfar A, Banihosseinian M

Πηγή‎: Iran J Ped Hematol Oncol 2014;4(4):151-9.

Καταχώριση‎: PubMed 25598955

https://www.ncbi.nlm.nih.gov/pubmed/25598955 (ανοίγει νέο παράθυρο)

2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer. (ανοίγει νέο παράθυρο)

Marec-Berard P, Chastagner P, Kassab-Chahmi D, Casadevall N, Marchal C, Misset JL, Ray-Coquard I.

Πηγή‎: Pediatr Blood Cancer 2009;53(1):7-12.

Καταχώριση‎: PubMed 19229970

DOI‎: 10.1002/pbc.21953

https://www.ncbi.nlm.nih.gov/pubmed/19229970 (ανοίγει νέο παράθυρο)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (ανοίγει νέο παράθυρο)

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Πηγή‎: Cancer 2013;119(1):107-14.

Καταχώριση‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 (ανοίγει νέο παράθυρο)

Erythropoietic growth factors for children with cancer: a systematic review of the literature. (ανοίγει νέο παράθυρο)

Mystakidou K, Potamianou A, Tsilika E

Πηγή‎: Curr Med Res Opin 2007;23(11):2841-7.

Καταχώριση‎: PubMed 17910805

DOI‎: 10.1185/030079907x242601

https://www.ncbi.nlm.nih.gov/pubmed/17910805 (ανοίγει νέο παράθυρο)

Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. (ανοίγει νέο παράθυρο)

Razzouk BI, Hord JD, Hockenberry M, Hinds PS, Feusner J, Williams D, Rackoff WR

Πηγή‎: J Clin Oncol 2006;24(22):3583-9.

Καταχώριση‎: PubMed 16877725

DOI‎: 10.1200/JCO.2005.03.4371

https://www.ncbi.nlm.nih.gov/pubmed/16877725 (ανοίγει νέο παράθυρο)

The role of recombinant erythropoietin in childhood cancer. (ανοίγει νέο παράθυρο)

Shankar AG

Πηγή‎: Oncologist 2008;13(2):157-66.

Καταχώριση‎: PubMed 18305061

DOI‎: 10.1634/theoncologist.2007-0126

https://www.ncbi.nlm.nih.gov/pubmed/18305061 (ανοίγει νέο παράθυρο)

Efficacy and safety of iorEPOCIM for chemotherapy- or radiotherapy-induced anemia in pediatric cancer patients. (ανοίγει νέο παράθυρο)

Vargas A, Mendoza I, Uranga R, González A, Martínez L, Caballero I, Piedra P, Saurez G, Verdecia M, Cabanas R

Πηγή‎: MEDICC Rev 2010;12(3):27-31.

Καταχώριση‎: PubMed 20697335

DOI‎: 10.37757/MR2010.V12.N3.7

https://www.ncbi.nlm.nih.gov/pubmed/20697335 (ανοίγει νέο παράθυρο)

A single institutional experience: is epoetin alpha effective in anemic children with cancer? (ανοίγει νέο παράθυρο)

Yilmaz D, Cetingül N, Kantar M, Oniz H, Kansoy S, Kavakli K

Πηγή‎: Pediatr Hematol Oncol 2004;21(1):1-8.

Καταχώριση‎: PubMed 14660300

https://www.ncbi.nlm.nih.gov/pubmed/14660300 (ανοίγει νέο παράθυρο)

Single dose darbepoetin alfa is useful in reducing red cell transfusions in leukemic children receiving chemotherapy. (ανοίγει νέο παράθυρο)

Zachariah M, Elshinawy M, Alrawas A, Bashir W, Elbeshlawi I, Tony S, Wali Y

Πηγή‎: Pediatr Hematol Oncol 2014;31(5):442-7.

Καταχώριση‎: PubMed 24088186

DOI‎: 10.3109/08880018.2013.824527

https://www.ncbi.nlm.nih.gov/pubmed/24088186 (ανοίγει νέο παράθυρο)

Early epoetin alfa treatment in children with solid tumors. (ανοίγει νέο παράθυρο)

Zoubek A, Kronberger M

Πηγή‎: Med Pediatr Oncol 2002;39(4):459-62.

Καταχώριση‎: PubMed 12203664

DOI‎: 10.1002/mpo.10186

https://www.ncbi.nlm.nih.gov/pubmed/12203664 (ανοίγει νέο παράθυρο)

Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. (ανοίγει νέο παράθυρο)

Crary SE, Hall K, Buchanan GR.

Πηγή‎: Pediatr Blood Cancer 2011;56(4):615-9.

Καταχώριση‎: PubMed 21298748

DOI‎: 10.1002/pbc.22930

https://www.ncbi.nlm.nih.gov/pubmed/21298748 (ανοίγει νέο παράθυρο)

Intravenous iron sucrose for children with iron deficiency anemia. (ανοίγει νέο παράθυρο)

Kaneva K, Chow E, Rosenfield CG, Kelly MJ

Πηγή‎: J Pediatr Hematol Oncol 2017;39(5):e259-62.

Καταχώριση‎: PubMed 28562517

DOI‎: 10.1097/MPH.0000000000000879

https://www.ncbi.nlm.nih.gov/pubmed/28562517 (ανοίγει νέο παράθυρο)

Advances in Pediatric Intravenous Iron Therapy. (ανοίγει νέο παράθυρο)

Mantadakis E.

Πηγή‎: Pediatr Blood Cancer 2016;63(1):11-6.

Καταχώριση‎: PubMed 26376214

DOI‎: 10.1002/pbc.25752

https://www.ncbi.nlm.nih.gov/pubmed/26376214 (ανοίγει νέο παράθυρο)

The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. (ανοίγει νέο παράθυρο)

Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B.

Πηγή‎: Cochrane Database Syst Rev 2016;(2):CD009624.

Καταχώριση‎: PubMed 26845108

DOI‎: 10.1002/14651858.CD009624.pub2

https://www.ncbi.nlm.nih.gov/pubmed/26845108 (ανοίγει νέο παράθυρο)

Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha. (ανοίγει νέο παράθυρο)

Pedrazzoli P, Farris A, Del Prete S, Del Gaizo F, Ferrari D, Bianchessi C, Colucci G, Desogus A, Gamucci T, Pappalardo A, Fornarini G, Pozzi P, Fabi A, Labianca R, Di Costanzo F, Secondino S, Crucitta E, Apolloni F, Del Santo A, Siena S.

Πηγή‎: J Clin Oncol 2008;26(10):1619-25.

Καταχώριση‎: PubMed 18375891

DOI‎: 10.1200/JCO.2007.12.2051

https://www.ncbi.nlm.nih.gov/pubmed/18375891 (ανοίγει νέο παράθυρο)

Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron. (ανοίγει νέο παράθυρο)

Plummer ES, Crary SE, McCavit TL, Buchanan GR

Πηγή‎: Pediatr Blood Cancer 2013;60(11):1747-52.

Καταχώριση‎: PubMed 23832487

DOI‎: 10.1002/pbc.24676

https://www.ncbi.nlm.nih.gov/pubmed/23832487 (ανοίγει νέο παράθυρο)